Israel's Teva gets FDA nod for generic version of Uniretic

March 9 (Reuters) - Teva Pharmaceutical Industries Ltd. (TEVA.O) said the U.S. Food and Drug Administration has approved its generic version of Schwarz Pharma's (SRZG.DE) Uniretic tablets, a treatment for hypertension.

In a news statement, Teva said shipment of the Moexipril HCl and Hydrochlorothiazide tablets will begin immediately.

(Reporting by Sweta Singh in Bangalore)

((Editing by Valerie Lee; Reuters messaging: sweta.singh.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: TEVA FDA/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS3627